Author:
Karnes H. Thomas,Shah Kumar A.
Reference28 articles.
1. Shah VP (1987) Analytical methods used in bioavailability studies: a regulatory viewpoint. Clin Res Regul Aff 5:51–60
2. Karnes HT, Shiu G, Shah VP (1991) Validation of bioanalytical methods. Pharm Res 8(4):421–426
3. U.S. Department of Health & Human Services. Guidance for industry: bioanalytical method validation. FDA, CDER, CVM, May 2001 BP
4. Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, Layloff T, Viswanathan CT, Cook CE, McDowall RD, Pittman KA, Spector S (1992) Conference report. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Pharm Res 9(4):588–592
5. U.S. Department of Health & Human Services. Guidance for industry. Bioanalytical methods validation for human studies. FDA, CDER, Dec. 1998 BP